ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab
January 19, 2023SOTIO Biotech announced today that the first patient was dosed in its Phase 2 AURELIO-05 combination trial of nanrilkefusp alfa (previously known as SOT101), an IL-15 superagonist, and cetuximab in patients with colorectal cancer. -
Top Oncologist, Dr Samuel Fourie, Joins Advisory Board of AzarGen Biotechnologies
November 17, 2018AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa), a company focused on developing human therapeutic proteins using advanced genetic engineering and synthetic biology techniques in plants, is pleased to announce that Dr. Samuel Fourie, an onc -
Top Oncologist, Dr Samuel Fourie, Joins Advisory Board of AzarGen Biotechnologies
November 17, 2018AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa), a company focused on developing human therapeutic proteins using advanced genetic engineering and synthetic biology techniques in plants, is pleased to announce that Dr. Samuel Fourie, an onc
Pharma Sources Insight January 2025
